N@N

BAK, VNDA, MDC, GLP, SNTA, LXRX Expected To Be Down Before Next Earnings Releases

April 26, 2012 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released in the coming weeks and determining how the stocks have performed Before their last 12 quarterly, 6 quarterly and June earnings reports. Braskem SA (NYSE:BAK), Vanda Pharmaceuticals Inc (NASDAQ:VNDA), MDC Holdings Inc (NYSE:MDC), GLOBAL PARTNERS LP (NYSE:GLP), SYNTA PHARMACEUTICALS CORP (NASDAQ:SNTA), LEXICON PHARMACEUTICALS INC (NASDAQ:LXRX) are all expected to be Down Before their earnings are released. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act after its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php . The following stocks are expected to go Down Before earnings are released Thursday:

  Symbol  Company                          # of Reports         Quarter  Release Date
  BAK     Braskem SA                       6 Quarter            Q1       05/10/2012
  VNDA    Vanda Pharmaceuticals Inc        12 Quarter           Q1       05/08/2012
  MDC     MDC Holdings Inc                 6 Quarter            Q1       05/03/2012
  GLP     GLOBAL PARTNERS LP               12 Quarter           Q1       05/03/2012
  SNTA    SYNTA PHARMACEUTICALS CORP       6 Quarter            Q1       05/03/2012
  LXRX    LEXICON PHARMACEUTICALS INC      6 Quarter            Q1       05/03/2012

This technology is designed to help the stock trader identify those companies that seem to have a consistent pattern of movement before or after the earnings release date, based on the history of earnings releases for that company. It combines a calendar of expected earnings releases with a history of past earnings releases in a way that lets you see if a pattern exists.

Braskem SA (NYSE:BAK) - Braskem S.A. produces and sells petrochemical products in Brazil and the United States. It offers olefins, such as ethylene, polymer and chemical grade propylene, butadiene, isoprene, and butene-1; aromatics comprising benzene, toluene, para-xylene, ortho-xylene, and mixed xylene; fuels, such as automotive gasoline and liquefied petroleum gas; and other basic petrochemicals, such as ethyl tertiary butyl ether, solvent C9, and pyrolysis C9 primarily for manufacturing intermediate second generation petrochemical products. The company provides polyethylene and polypropylene for use in consumer and industrial applications, such as plastic films for food and industrial packaging, bottles, shopping bags and other consumer goods containers, automotive parts, and household appliances. In addition, the company offers suspension polyvinylchloride (PVC) for the manufacture of pipes, fittings, laminated products, shoes, sheeting, flooring, cable insulation, electrical conduit, packaging, and medical applications; paste PVC for producing toys, synthetic leather, flooring materials, bottle caps and seals, automobile corrosion prevention treatments, and wallpaper coatings; and caustic soda for aluminum, pulp and paper, petrochemicals and other chemicals, soaps and detergents, and waste treatment plants applications. Further, it distributes chemical and petrochemical products comprising solvents, such as aliphatic, aromatic, synthetic, and ecological solvents; polymers; and general purpose chemicals, which include process oils, chemical intermediates, blends, specialty chemicals, pharmaceuticals, and santoprene. The company was formerly known as Copene Petroquimica do Nordeste S.A. The company was founded in 1972 and is headquartered in Camaari, Brazil. Braskem S.A. operates as a subsidiary of Odebrecht S.A.

Vanda Pharmaceuticals Inc (NASDAQ:VNDA) - Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of clinical-stage products for various central nervous system disorders. Its lead product includes Fanapt for the acute treatment of schizophrenia in adults. The company is developing Tasimelteon, which is in the orphan designation status for the treatment of non-24 hour sleep/wake disorder in blind individuals without light perception. It is also developing Tasimelteon in Phase II trials for the treatment of depression. The company was incorporated in 2002 and is headquartered in Rockville, Maryland.

MDC Holdings Inc (NYSE:MDC) - M.D.C. Holdings, Inc., through its subsidiaries, provides homebuilding and financial services in the United States. It operates in two segments, Homebuilding, and Financial Services and Other. The Homebuilding segment constructs and sells single-family detached homes to first-time and first-time move-up homebuyers under the Richmond American Homes name. The Financial Services and Other segment originates mortgage loans primarily for homebuyers, as well as brokers mortgage loans for origination by outside lending institutions. This segment also offers third party insurance products and title agency services to its homebuyers, as well as provides general liability coverage for construction work performed associated with closed homes. The company was founded in 1972 and is based in Denver, Colorado.

GLOBAL PARTNERS LP (NYSE:GLP) - Global Partners LP, through its subsidiaries, engages in the wholesale and commercial distribution of refined petroleum products and natural gas, and provides ancillary services in the United States and internationally. It operates in two segments, Wholesale and Commercial. The Wholesale segment sells gasoline, home heating oil, diesel, kerosene, and residual oil to unbranded retail gasoline stations and other resellers of transportation fuels, home heating oil retailers, and wholesale distributors. The Commercial segment sells unbranded gasoline, home heating oil, diesel, kerosene, and residual oil to the public sector, and commercial and industrial customers. This segment also purchases, custom blends, sells, and delivers bunker fuel and diesel to cruise ships, bulk carriers, and fishing fleets generally by barges. It serves federal and state agencies, municipalities, and industrial companies; autonomous authorities, such as transportation authorities and water resource authorities, colleges, and universities; and a group of small utilities. As of December 31, 2009, the company owned, leased, or maintained storage facilities at 22 refined petroleum product bulk terminals with the capacity of approximately 50,000 barrels. Global GP LLC serves as the general partner of the company. Global Partners LP is based in Waltham, Massachusetts.

SYNTA PHARMACEUTICALS CORP (NASDAQ:SNTA) - Synta Pharmaceuticals Corp., a biopharmaceutical company, focuses on discovering, developing, and commercializing small molecule drugs to extend and enhance the lives of patients with severe medical conditions, including cancer and chronic inflammatory diseases. Its research and development programs include STA-9090, an Hsp90 inhibitor that is in Phase II stage for non-small cell lung cancer and gastrointestinal stromal tumors, as well as in Phase I for hematologic cancers and solid tumors; Elesclomol, an oxidative stress inducer that is in Phase I/II stage for solid and hematologic cancers; and STA-9584, a vascular disrupting agent, which is in preclinical development for cancer. The companys programs also include Apilimod (STA-5326), an oral IL-12/23 inhibitor, which is in Phase IIa stage for rheumatoid arthritis; and Oral CRACMchannelinhibitor that is in preclinical development for autoimmune diseases and respiratory conditions. It has a partnership with Hoffmann-La Roche for the development of CRACM inhibitors; and a joint collaboration with The Multiple Myeloma Research Foundation Inc. for the clinical development of ganetespib in patients with multiple myeloma. The company was incorporated in 2000 and is based in Lexington, Massachusetts.

LEXICON PHARMACEUTICALS INC (NASDAQ:LXRX) - Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of human diseases in the areas of cardiology, gastroenterology, immunology, metabolism, and ophthalmology. The companys drug candidates include LX1031, which has completed Phase II clinical trials for the treatment of irritable bowel syndrome and other gastrointestinal disorders; LX4211 that has completed Phase II clinical trials to treat type 2 diabetes; LX2931, which is in Phase II clinical trials for the treatment of rheumatoid arthritis and other autoimmune diseases; and LX1032 that has completed Phase II clinical trials to treat the symptoms associated with carcinoid syndrome. It also has a preclinical development drug candidate, LX7101, for the treatment of glaucoma. The company has drug discovery alliances with Bristol-Myers Squibb Company; Genentech, Inc.; N.V. Organon; and Takeda Pharmaceutical Company Limited. It also has drug development financing collaboration with Symphony Icon; and an alliance with Nuevolution A/S, which provides access to Nuevolutions Chemetics platform chemistry technology. Lexicon Pharmaceuticals, Inc. was formerly known as Lexicon Genetics Inc. and changed its name on April 26, 2007. The company was founded in 1995 and is headquartered in The Woodlands, Texas.

SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com

www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.

INVESTMENTS & TRADING

SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

About SQUEEZETRIGGER.COM

WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.

SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.

Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.

By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.

Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641